Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Roxadustat vs erythropoietin for cardiac structure and function in hemodialysis patients
ChiCTR2000041202Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Chongqing Medical University
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of roxadustat in chronic kidney disease (CKD), anemia of renal disease and left ventricular hypertrophy (LVH) (2 arms), sponsored by The Third Affiliated Hospital of Chongqing Medical University. Primary endpoints: Left ventricular mass index and Cardiac ejection fraction. Started Dec 2020; status: recruiting.
02
Drugs
roxadustat
03
Conditions
chronic kidney disease (CKD)anemia of renal diseaseleft ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on ChiCTR2000041202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041202.